関連する実験動画
Updated: Feb 14, 2026

08:06
Robotic Cochlear Implantation for Direct Cochlear Access
Published on: June 16, 2022
4.1K
小児コクリアインプラントの後のリハビリテーションの結果の予測要因
Ke Wang1, Zhihan Lin1, Meiling Yan1
1Department of Otolaryngology, Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56, South Lishi Road, Xicheng District, Beijing 100045, China.
Journal of clinical medicine
|February 13, 2026
まとめ
子どもにおける頭インプランテーション (CI) の成功は,多くの要因に依存します. 早期のインプラント,よりよい術前技能,および特定の遺伝要因は,手術後の聴覚と言語の改善を予測します.
科学分野:
- オーディオロジー オーディオロジー
- 小児 otorhinolaryngology (小児 otorhinolaryngology) とは,小児 otorhinolaryngology (小児 otorhinolaryngology) とは,小児 otorhinolaryngology (小児 otorhinolaryngology) とは,小児 otorhinolaryngology (小児 otorhinolaryngology) とは,小児 otorhinolaryngology (小児 otorhinolaryngology) とは,小児 otorhinolaryngology (小児 otorhinolaryngology) とは,小児 otorhinolaryngology (小児 otorhinolaryngology) とは,小児 otorhinolaryngology (小児 otorhinolaryngology) とは
- 発達小児科 発達小児科
背景:
- コケアインプラント (CI) は,小児の難聴に対する重要な介入です.
- C.I.後のリハビリテーションの結果には大きな変動がある.
- 成功の予測要因を特定することは,小児ICケアの最適化に不可欠です.
研究 の 目的:
- 小児の内臓移植におけるリハビリテーションの成功を予測する要因に関する現在の証拠をレビューする.
- 結果に影響を与える一般的,聴覚特異的,外科的変数に関する情報を合成する.
主な方法:
- 現代の証拠の体系的なレビュー.
- 子どもにおけるCI後のリハビリテーションの成功の予測要因を調査した研究のまとめ.
主要な成果:
- 早期のインプラント年齢,より強い手術前言語/スピーチスキル,より高い認知能力,および親の教育に関連した好ましい結果.
- 聴覚特異的予測因子には,遅発の難聴,短期の難聴,および特定可能な病因 (GJB2,OTOF変異など) が含まれる.
- 二国間CI,同時インプラント,および特定の外科技術 (電極配列の選択/配置) が結果に影響します.
結論:
- 小児のCI結果は,生物学的,発達的,環境的要因の複雑な相互作用の結果である.
- これらの予測要因を理解することで,小児ICの成功率を向上させるためのリハビリテーション戦略を調整するのに役立ちます.
関連する概念動画
Predicting Reaction Outcomes
11.0K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Outcomes of Glycolysis
107.8K
Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.8K
Guidelines for Writing Outcome
4.1K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion
279
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Pharmacokinetics in Pediatric Patients: Drug Distribution
334
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism
247
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
247

